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Peeling skin syndrome is an autosomal recessive genodermatosis characterized by the shedding of the outer epidermis.
In the acral form, the dorsa of the hands and feet are predominantly affected. Ultrastructural analysis has revealed
tissue separation at the junction between the granular cells and the stratum corneum in the outer epidermis.
Genomewide linkage analysis in a consanguineous Dutch kindred mapped the gene to 15q15.2 in the interval
between markers D15S1040 and D15S1016. Two homozygous missense mutations, T109M and G113C, were
found in TGM5, which encodes transglutaminase 5 (TG5), in all affected persons in two unrelated families. The
mutation was present on the same haplotype in both kindreds, indicating a probable ancestral mutation. TG5 is
strongly expressed in the epidermal granular cells, where it cross-links a variety of structural proteins in the terminal
differentiation of the epidermis to form the corniﬁed cell envelope. An established, in vitro, biochemical cross-
linking assay revealed that, although T109M is not pathogenic, G113C completely abolishes TG5 activity. Three-
dimensional modeling of TG5 showed that G113C lies close to the catalytic domain, and, furthermore, that this
glycine residue is conserved in all known transglutaminases, which is consistent with pathogenicity. Other families
with more-widespread peeling skin phenotypes lacked TGM5 mutations. This study identiﬁes the ﬁrst causative
gene in this heterogeneous group of skin disorders and demonstrates that the protein cross-linking function per-
formed by TG5 is vital for maintaining cell-cell adhesion between the outermost layers of the epidermis.
Introduction
Peeling skin syndrome (PSS [MIM 270300]) is an au-
tosomal recessive disorder characterized by the contin-
uous shedding of the outer layers of the epidermis from
birth and throughout life (Kurban and Azar 1969; Levy
and Goldsmith 1982; Abdel-Hafez et al. 1983; Silver-
man et al. 1986; Mevorah et al. 1987; Judge et al. 2004).
Histological and ultrastructural analyses in a number of
cases have shown that the level of blistering in PSS is
high in the epidermis, at the junction of the stratum
granulosum (the last living layer) and the stratum cor-
neum (the terminally differentiated and continuously
shed, corniﬁed squamous layers). Thus, the disorder is
histologically distinguishable from the various forms of
epidermolysis bullosa, in which blistering occurs in the
basal keratinocytes of the epidermis (for simplex forms,
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see Lane and McLean 2004), within or close to the der-
mal-epidermal basement membrane (for junctional var-
iants, see Uitto and Richard 2004), or in the upper pap-
illary dermis (for dystrophic forms, see Uitto and
Richard 2004). In some cases of PSS, skin peeling is
accompanied by erythema, vesicular lesions, or, in rare
cases, other ectodermal features, like fragile hair and nail
abnormalities. Two main subtypes, noninﬂammatory
type A and inﬂammatory type B, have been suggested
(Traupe 1989; Judge et al. 2004); however, it is clear
from the dermatology literature that there are additional
subtypes. In some families, an acral form of PSS (APSS)
has been reported, in which skin peeling is strictly limited
to the dorsa of the hands and feet, and, again, ultra-
structural and histological analysis shows a level of blis-
tering high in the epidermis at the stratum granulosum–
stratum corneum junction (Shwayder et al. 1997; Hash-
imoto et al. 2000).
Transglutaminases (TGs) are involved in protein
cross-linking by catalyzing the formation of gamma-
glutamyl-lysine isodipeptide bonds between adjacent
polypeptides (Candi et al. 2005; Eckert et al. 2005).
This process is particularly important in the terminal
differentiation of the epidermis, where TGs heavily
cross-link keratins and a range of differentiation-speciﬁc
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Table 1
Primers for TGM5 Ampliﬁcation
This table is available in its entirety in the online
edition of The American Journal of Human Genetics.
structural proteins, such as involucrin, loricrin, ﬁlag-
grin, and small proline-rich proteins, in the formation
of the corniﬁed cell envelope in the biogenesis of the
stratum corneum, the outermost, “dead” layer of the
epidermis (Kalinin et al. 2002). This continuously shed
outer layer of the epidermis performs the main barrier
function of the skin. Recessive loss-of-function muta-
tions in TGM1 have been shown to cause lamellar ich-
thyosis, a disease characterized by excessive scaling and
shedding of the outer epidermis (Huber et al. 1995;
Parmentier et al. 1995; Russell et al. 1995). No genetic
disease associations have been reported so far for the
other major epidermal TGs, TG3 and TG5.
Here, we describe how we mapped a gene for APSS
to 15q15.2 and identiﬁed the same loss-of-function mu-
tations in the TGM5 gene in two unrelated families.
Material and Methods
Genetic Linkage
A genomewide screen was performed as described
elsewhere (van Steensel et al. 1999; Hamada et al. 2002)
with the use of the ABI Linkage Mapping Set version 2,
consisting of 400 ﬂuorescent microsatellite markers
placed at ∼10-cM intervals. PCRs formicrosatellite anal-
ysis were performed in a total volume of 7.5 ml con-
taining 100 ng of template DNA, 1# GeneAmp PCR
buffer II (Applied Biosystems), 330 nM of each primer,
250 mM dinucleotide triphosphates (dNTPs), 2.5 mM
MgCl2, and 0.30 units of Amplitaq Gold DNA poly-
merase (Applied Biosystems). Samples were ampliﬁed in
a Touchdown ThermoCycler (Hybaid) in accordance
with the following conditions: After an initial denatur-
ation at 94C for 2 min, samples were subjected to 35
cycles of 94C for 30 s, 56C for 30 s, and 72C for 30
s, followed by a ﬁnal incubation of 72C for 5 min. PCR
fragments were sized on an ABI 3100 DNA sequencer
with the use of Genescan and Genotyper software (Ap-
plied Biosystems). Two-point LOD scores were calcu-
lated with the MLINK algorithm of LINKAGE version
5.1, with the assumption that themutant allele frequency
was 0.0001 with 100% penetrance. Markers in the ho-
mozygous linked interval gave a maximum LOD score
of 5.6 at . The following primers were used tovp 0
amplify “homemade” microsatellites in the locus:
TGM5-MS1 (5′-GAATTGCTTGAACCTCGGAG-3′
and 5′-GAGTCAAGCTTTCAACCTGG-3′; ∼265 bp);
TGM5-MS2 (5′-GCTAGGGGTAGTGCTGAAGG-3′
and 5′-GGCTGGAAGCATAGTTCAGG-3′; ∼311 bp);
and TGM5-MS3 (5′-CAGGGCAAATTGGTGAACAG-
3′ and 5′-CCTCCAATTCCAAATGCTTA-3′; ∼401 bp).
TGM5 Mutation Analysis
All 13 exons, including splice sites and branch points,
were PCR ampliﬁed from genomic DNA and were di-
rectly sequenced with both forward and reverse primers
listed in table 1. For PCR, 200 ng of patient or control
genomic DNA was added to a premix containing 1#
PCR buffer (Promega), 10 nmol of each dNTP, 20 pmol
of each primer, and 1 unit of Taq polymerase (Promega),
in a total volume of 50 ml. After an initial denaturation
at 94C for 2 min, samples were subjected to 35 cycles
of 94C for 30 s, 56C for 30 s, and 72C for 60 s,
followed by a ﬁnal incubation of 72C for 5 min. The
PCR products were examined by agarose gel electro-
phoresis, were puriﬁed using spin columns (Qiagen), and
were directly sequenced using BigDye Terminators on
an ABI 3100 genetic analyzer (Applied Biosystems).
Construction of TG5 Expression Vectors
Full-length, wild-type human TG5 complementary
DNA (cDNA) (Candi et al. 2001) cloned in a mam-
malian expression vector pCDNA3.1 was used as the
template for the two mutant forms, T109M and G113C.
Mutations were inserted by PCR ampliﬁcation of the
wild-type plasmid (Platinum HiFi Taq-Polymerase [In-
vitrogen]) with the use of primers carrying the selected
mutations. The PCR product was digested (DpnI [Pro-
mega]), was ligated (DNA Ligation Kit v.2.0 [Takara]),
and was transformed into a DH5-a bacterial strain (In-
vitrogen). Positive clones were selected by direct se-
quencing of mutagenesis sites. The following primers
were used for the introduction of mutations: G113C
5′-ATCCACATCGACTCCTTCCAGGGG-3′ and 5′-
TTTCAAGAGGTACCGACACACGGC-3′; and T109M
5′-CGGTACCTCTTGAAAATCCACATC-3′ and5′-
ACCCACGGCCGCCATGGGAG-3′. The following
PCR programwas used for both mutants: a denaturation
step of 4 min at 95C, followed by 16 cycles of 94C
for 40 s, 61C for 45 s, and 70C for 2 min and 30 s,
and followed by a ﬁnal step of 10 min at 72C.
Cell Culture and Transfection
Cryopreserved NHEK cells obtained from Bio-
Whittaker were grown in calf skin collagen–coated
dishes (Sigma Chemical) in serum-free keratinocyte me-
dium (BioWhittaker) at 0.05 mM Ca2 and supple-
mented with Single-Quots (BioWhittaker) containing
7.5 mg/ml bovine pituitary extract, 0.5 mg/ml insulin,
0.5 mg/ml hydrocortisone, and 0.1 mg/ml hEGF. Third-
passage cells were used for transfection experiments.
HEK-293 cells were grown in Dulbecco’s modiﬁed Eagle
medium, supplemented with 10% (v/v) fetal bovine se-
rum. Cells were transiently transfected using Effectene
Figure 1 Clinicopathological features of APSS. a–d, Superﬁcial peeling of the skin, leaving residual, painless erythema (best seen in a and
d). d, Painless, manual skin removal is also possible, demonstrating that the peeling is limited to the stratum corneum. e, Light microscopy of
a representative skin lesion on the dorsum of the foot (proband of family 2). The arrows point to the level of dehiscence, where cytolysis can
be seen. No other abnormalities are evident. f, Electron microscopy of a similar lesion (proband of family 1, 20,000# magniﬁcation), where
B denotes a blister. The level of separation is evidently between the uppermost granular layer cells (GC) and the acellular stratum corneum
(SC). The asterisks mark tonoﬁlaments that appear intact. Widened spaces (s) were observed in the stratum corneum, but these can be seen in
skin from normal individuals (not shown) and are probably artefactual.
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Figure 2 Pedigrees of APSS families 1 and 2 showing haplotype information in the vicinity of the TGM5 locus on 15q15. In family 1,
of Dutch origin, two brothers married two sisters in generation II, and both resulting sibships produced affected children with APSS. At the
outset, consanguinity could not be formally established, so compound heterozygous linkage was sought. This was identiﬁed for markers in the
interval between D15S1040 (recombinant) and D15S1016 (recombinant), where all affected persons inherited the same two haplotypes (red
and black boxes), whereas the unaffected individuals III-1 and III-5 inherited only one or the other of these haplotypes. Within the interval,
homozygosity-by-descent was identiﬁed with markers ﬂanking the TGM5 gene (bold type). Subsequently, a genealogical connection between
the grandparents in generation I (dotted lines) was traced back to the 1780s, conﬁrming the distant consanguinity implied by the genotype
data. Interestingly, the proband in family 2 was homozygous for the same haplotype close to the TGM5 gene. This family was nonconsanguineous
and of Scottish origin, with no history of Dutch ancestry.
(Qiagen) reagents in accordance with themanufacturer’s
instructions, with the use of 1.5 mg of pCDNA3.1-TG5-
myc and mutant expression vectors. Aliquots of the ex-
tracted enzymes were used for the TG assay.
TG Activity Assay
TG activity was determined by measuring the incor-
poration of [3H]putrescine (Amersham) into N,N′-di-
methyl-casein (Sigma Chemicals), as described elsewhere
(Candi et al. 2001). The reactionmixtures contained 100
mM Tris-HCl at pH 8.5, 100 mM NaCl, 5 mM DTT,
10 mM CaCl2, 25 ml of casein (12.5 mg/ml), and 0.2
mM putrescine containing 1 mCi [3H]putrescine. Differ-
ent samples were incubated with the reaction mixture
in a ﬁnal volume of 100 ml at 37C. After 10 min of
incubation, the reaction was stopped by spotting 25-ml
aliquots on Whatman 3MM ﬁlter paper. Unbound
[3H]putrescine was removed by washing with large vol-
umes of 15%, 10%, and 5% trichloroacetic acid and
absolute ethanol. Filters were then air dried, and the
radioactivity was measured by liquid scintillation count-
ing. The TG assay was performed in triplicate. The ac-
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Figure 3 Summary of genome scan data obtained for APSS fam-
ily 1, chromosomes 1–10, with microsatellite markers from Applied
Biosystems Linkage Mapping Set version 2. This legend is available
in its entirety in the online edition of The American Journal of Human
Genetics.
Figure 4 Summary of genome scan data obtained for APSS fam-
ily 1, chromosomes 11–22, with microsatellite markers from Applied
Biosystems Linkage Mapping Set version 2. This legend is available
in its entirety in the online edition of The American Journal of Human
Genetics.
tivities measured in different samples were normalized
by protein content and by transfection efﬁciency to com-
pare cells transfected with different expression vectors.
TG5 Three-Dimensional Modeling
A three-dimensional model of human TG5 was gen-
erated using MODELLER (Sali and Blundell 1993). The
crystal structure of human TG2 (Protein Data Bank
identiﬁcation number 1KV3) was used as a starting
point. Human TG2 and TG5 have a 41% sequence iden-
tity, and their sequences were aligned using LALIGN
v.2.0u6. The alignment was input into MODELLER to
model TG5 by satisfying spatial restraints. The model
was optimized using the molecular probability density
function by conjugate gradient and simulated annealing.
Relative to TG2, TG5 has a 29–amino-acid insertion
between the b-barrel 1 and the catalytic core, which
could not be modeled.
Results
APSS Phenotype and Linkage Mapping
Here, we studied two families with noninﬂammatory
APSS, where peeling was accompanied by erythema and
was limited to the acral regions of the skin, predomi-
nantly over the hands and feet (ﬁg. 1). Affected patients
experienced periodic, painless, and superﬁcial skin peel-
ing. Although the skin peeling occurred spontaneously,
the manual removal of strips of skin was easy. The ab-
normality was exacerbated by elevated ambient tem-
perature and humidity. The peeled areas showed some
residual erythema for a few days but healed spontane-
ously and without scarring. Similar families have been
described elsewhere (Shwayder et al. 1997; Hashimoto
et al. 2000), and so APSS represents a clinically recog-
nizable entity. Family 1 was of Dutch origin and included
ﬁve affected individuals in two interbred sibships (ﬁg.
2). Genealogical analysis was able to establish distant
consanguinity dating back to the 1780s (data not
shown). Family 2 was of Scottish origin (ﬁg. 2) and
presented with clinical features essentially identical to
those observed in family 1 (data not shown). In this case,
consanguinity was unknown. A genomewide screen was
performed on family 1 with the use of 400 microsatellite
markers spaced at ∼10-cM intervals. Because of the ini-
tial uncertainty over consanguinity, the regions where
all ﬁve affected individuals showed homozygosity or
were heterozygous for the same two marker alleles were
considered to be potentially linked loci. The genome scan
data are summarized in ﬁgures 3 and 4. In the end, only
two loci showed homozygosity,D1S2797 andD13S285,
both of which were poorly informative, and these loci
were subsequently excluded by nearby ﬂanking markers
(data not shown). One linked locus was identiﬁed on
15q15.2 between markers D15S1012 and D15S978, in
which all ﬁve affected individuals were heterozygous for
the same alleles and their unaffected sibs had differing
genotypes (ﬁg. 2). High-density microsatellite analysis in
this region conﬁrmed compound heterozygous linkage
over a 10.2-Mb region, with visible recombination seen
with markers D15S1040 and D15S1016 (ﬁg. 2). How-
ever, “homemade” microsatellites (TGM5-MS1 and
TGM5-MS3) in the central ∼270-kb region within this
interval showed homozygosity-by-descent in all affected
individuals and heterozygosity in the unaffected parents
and siblings, which was consistent with consanguinity
in the pedigree and was predictive of a homozygous
mutation. These markers were chosen because they ﬂank
a strong candidate gene, TGM5, as described below.
Linkage analysis gave a statistically signiﬁcantmaximum
two-point LOD score of 5.6 at for informativevp 0
markers within the area of homozygosity-by-descent in
family 1. Surprisingly, the proband in family 2was found
to also be homozygous for the same alleles of markers
TGM5-MS1 and TGM5-MS3 within the linked area,
predicting the same genetic lesion in both families.
APSS Maps to a TG Gene Cluster
The critical interval of shared haplotypes contained
nine genes (UCSC Genome Browser, May 2004 build).
Located centrally in the locus was a small cluster of TG
genes,TGM5, TGM7, andEPB42 (Grenard et al. 2001).
These TG genes represented good candidates for APSS.
Of the three genes in this cluster, TGM7 and EPB42
had expression patterns inconsistent with an epidermal
phenotype (Grenard et al. 2001). Furthermore, loss-of-
expression mutations in EPB42 are known to cause re-
cessive spherocytic elliptocytosis (MIM 177070) (Ry-
bicki et al. 1988; Bouhassira et al. 1992). TGM5 is
widely expressed but, signiﬁcantly, it has been shown to
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Figure 5 Identiﬁcation of homozygous missense mutations in
TGM5 in persons affected by APSS. a, Normal coding-strand DNA
sequence derived from exon 3 of the TGM5 gene, showing codons
108–114 inclusive. b, The same region of TGM5, derived from the
proband in family 1 (individual III-3). Two homozygous missense mu-
tations are shown: 326CrT (left arrow) and 337GrT (right arrow),
predicting the amino acid changes T109M and G113C, respectively.
c, The same region of TGM5, derived from a heterozygous carrier in
family 1 (individual III-5). All affected persons in families 1 and 2
were homozygous for both changes.
be strongly expressed in the epidermis, with maximal
expression in the vicinity of the junction between the
stratum granulosum and the stratum corneum (Candi et
al. 2002), which is precisely where intraepidermal split-
ting was seen to occur in our APSS families (ﬁg. 1e and
1f). Furthermore, TGM5 is also known to cross-link the
structural proteins loricrin, involucrin, and small pro-
line-rich proteins in vitro, all of which localize to this
region of the epidermis (Candi et al. 2001). Thus, we
considered TGM5 to be a prime candidate gene for
APSS, in terms of its function and expression pattern.
TGM5 consists of 13 exons spanning 33.7 kb of ge-
nomic DNA and encoding two major splice variants
(Grenard et al. 2001). Mutation analysis of all exons
and splice sites of TGM5 revealed two homozygous mis-
sense mutations, T109M and G113C, in all six affected
members of families 1 and 2 (ﬁg. 5). The clinically un-
affected parents and siblings available for study were
heterozygous for these changes, as consistent with the
linkage data (ﬁg. 2). Screening of 100 Dutch and 50
British controls by sequencing revealed one Dutch in-
dividual who was heterozygous for both mutations and
had no history of skin peeling. On the basis of these
data, we would predict an incidence of ∼1 in 90,000
affected persons in the population, a ratio that is com-
patible with the rarity of APSS when compared with
other epidermal blistering conditions such as epider-
molysis bullosa simplex, which has an incidence of ∼1
in 20,000 in the Scottish population (Horn et al. 1997).
Functional Conﬁrmation of Pathogenicity
To further conﬁrm that one or both of these missense
mutations were, in fact, pathogenic, we made full-length
expression constructs for TG5, into which we intro-
duced the mutations, either singly or together. With the
use of a well-established assay system (Candi et al.
2001), these constructs were used to measure TG5 en-
zyme activity following transfection into two different
epithelial cell lines (ﬁg. 6). In both cell lines, the missense
change T109M did not signiﬁcantly reduce TG5 activity;
however, G113C completely abolished cross-linking ac-
tivity, as did the double mutation (ﬁg. 6). Thus, the
G113C mutation is pathogenic, and T109M probably
represents a rare polymorphism present on the same al-
lele. Of the nine known human TGs, only TG5 has a
threonine at this position; the other TGs have either
asparagine ( ), serine ( ), lysine ( ), ornp 4 np 2 np 1
aspartic acid ( ). Therefore, a variety of changesnp 1
can apparently be tolerated in this position without af-
fecting TG activity.
A computer model of human TG5 was generated from
the published three-dimensional structure of human
TG2 (ﬁg. 6c and 6d). Not surprisingly, given the high
degree of homology (41% identity), the overall predicted
structure of TG5 closely matched that of TG2. This anal-
ysis showed that the mutation T109M is located at the
surface of the enzyme and is, therefore, not likely to
affect the structural integrity of the enzyme, which con-
ﬁrms the biochemical studies and possibly explains the
poor evolutionary conservation of this residue. In con-
trast, Gly113 is conserved in all members of the TG
family from many species and is located near the hinge
region between the TG N-terminal domain and the cat-
alytic domain. This new cysteine found in the mutant
protein may form an unnatural disulﬁde bond that could
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Figure 6 Biochemical studies of TG5 mutant forms. NHEK (a) and HEK-293 (b) cells were transfected for 48 h with the use of wild-
type TG5 and the three mutant forms indicated. Total TG5 activities were measured for insoluble and fractions and standardized for transfection
efﬁciency (GFP). The control vector indicates the endogenous TG5 activity (cells transfected only with the GFP control vector). The data obtained
are reported as percentages of TG activity, with 100% corresponding to the activity for cells transfected with the wild-type construct. The data
presented are the averages of two independent experiments. c, View of the entire TG5 model with the four main structural domains. The
mutations described here are located in the N-terminal domain at the interface between the N-terminal domain and the catalytic domain. d,
Effects of the mutations in a local environment. The G113C mutation, close to the active site, would probably cause a local change in the main
protein structure. The poorly conserved residue T109 is present on the surface and is, therefore, unlikely to be functionally critical. Green
indicates the mutated residues, and red represents wild-type TG5 residues.
disrupt the nearby active site. In addition, the mutation
of the equivalent glycine residue in TG1 (G217S) has
been described in a patient affected by autosomal re-
cessive congenital ichthyosis (Laiho et al. 1997), show-
ing that this highly conserved glycine is required for TG
function.
Discussion
Here we have demonstrated that the abolition of TG5
activity in the skin, caused by homozygosity for the mis-
sense mutation G113C in exon 3 of TGM5, leads to an
acral-dorsal site-restricted form of PSS. This not only
explains the genetic defect underlying APSS but also
demonstrates that the protein cross-linking function per-
formed by TG5 (Candi et al. 2001) is vital for main-
taining cell-cell adhesion between the granular layer of
the epidermis and the overlying stratum corneum (ﬁg.
1e and 1f). TG5 is able to utilize a variety of classical
TG substrates in vitro, including loricrin, involucrin, and
small proline-rich proteins (Candi et al. 2001). However,
it is not yet clear which of these substrates is the pre-
dominant target of TG5 in vivo. TG5 is almost ubiq-
uitously expressed (Grenard et al. 2001) and, in partic-
ular, is widely expressed in the epidermis (Candi et al.
2002). In view of this, it is surprising that APSS affects
only the dorsal regions of the hands and feet (ﬁg. 1). We
speculate that there may be structurally important sub-
strates expressed in these epidermal regions that are
solely or preferentially cross-linked by TG5. Alterna-
tively, the expression of TG1 and TG3 may be lower in
these regions, so that TG5 activity predominates, al-
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though we have no experimental evidence to support
this because of the ethical difﬁculties in obtaining normal
biopsy material from these highly visible, cosmetically
sensitive sites.
Our patients report that peeling is exacerbated by
heat and humidity. Since an important function of the
stratum corneum is to form a water barrier (Kalinin et
al. 2002; Madison 2003), one might expect the hands
and feet to be particularly prone to a barrier defect
because of their greater environmental exposure to heat
and water. Another possible explanation is that there
are regional temperature differences in these areas of
the skin that affect the activity of the various epidermal
TGs. Sun exposure can probably be ruled out, since the
feet, which are mostly protected from the sun in our
patients, are affected about as much as the hands (ﬁg.
1).
The mutation described here occurs in exon 3 of the
TGM5 gene. This exon has been shown to be alternately
spliced (Candi et al. 2001; Grenard et al. 2001). Gren-
ard and colleagues reported isoform 1 (GenBank ac-
cession numbers NM_201631.1 and AF035961), which
includes all 13 exons, and also isoform 2 (GenBank
accession numbers NM_004245.1 and AF035960),
which lacks exon 3 (Grenard et al. 2001). Candi and
colleagues refer to isoform 2 as the “D3” form and also
reported an isoform lacking exon 11, to which they refer
as “D11” (Candi et al. 2001). There is no GenBank
accession number for the D11 isoform. By means of the
biochemical cross-linking assay for TG activity that was
used here, it was shown that the D3 isoform lacks TG
activity, at least that which was detectable by the pu-
trescine incorporation assay (Candi et al. 2001). The
fact that the lack of exon 3 leads to a loss of TG activity
is further evidence that the protein domain where the
G113C mutation is located is, in fact, a functionally
critical part of the protein required for enzymatic ac-
tivity. Nothing is currently known about the regional
variation in the alternate splicing of TGM5 transcripts,
which, again, might provide an explanation for the
acral-limited phenotype observed here; that is, enzy-
matically active isoforms containing exon 3 might be
preferentially expressed in the acral regions. Again, we
have been unable to investigate this because of the lack
of biopsy material, as discussed above.
Interestingly, we have excluded the TGM5 locus in a
large, consanguineous kindred of Middle Eastern origin
with more widespread peeling skin and, in addition,
have also failed to detect TGM5 mutations in three
small, outbred families with widespread peeling skin
phenotypes (Andrew J. Cassidy and W. H. Irwin Mc-
Lean, unpublished data). In all these families, the age
of onset was in infancy and the phenotype was similar
to the classical, generalized form of PSS described else-
where (Kurban and Azar 1969; Levy and Goldsmith
1982; Abdel-Hafez et al. 1983; Silverman et al. 1986;
Mevorah et al. 1987; Judge et al. 2004). One of the
small outbred families was reported elsewhere in the
literature (Levy and Goldsmith 1982). Thus, PSS is both
clinically and genetically heterogeneous, as is suggested
from diversity in clinical appearance reported in the
literature (Kurban and Azar 1969; Levy and Goldsmith
1982; Abdel-Hafez et al. 1983; Silverman et al. 1986;
Mevorah et al. 1987; Shwayder et al. 1997; Hashimoto
et al. 2000; Judge et al. 2004). The causative genes in
the cases presenting with generalized peeling skin may
shed further light on the preferred cross-linking sub-
strates for the epidermal TGs, particularly TG5, as well
as the key protein-protein interactions that are necessary
to maintain epidermal structural integrity and the im-
portant barrier function performed by the outermost
layers of the epidermis.
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.ncbi.nlm.nih.gov/Omim/ (for PSS and spherocytic ellip-
tocytosis)
Protein Data Bank, http://www.rscb.org/pdb/ (for crystal struc-
ture of human TG2 [identiﬁcation number 1KV3])
UCSC Genome Browser, http://www.genome.ucsc.edu/ (for
TGM5, TGM7, and EPB42)
References
Abdel-Hafez K, Safer AM, Selim MM, Rehak A (1983) Fa-
milial continual skin peeling. Dermatologica 166:23–31
Bouhassira EE, Schwartz RS, Yawata Y, Ata K, Kanzaki A,
Qiu JJ, Nagel RL, Rybicki AC (1992) An alanine-to-thre-
onine substitution in protein 4.2 cDNA is associated with
a Japanese form of hereditary hemolytic anemia (protein
4.2NIPPON). Blood 79:1846–1854
Cassidy et al.: TGM5 Mutations Cause Peeling Skin Syndrome 917
Candi E, Oddi S, Paradisi A, Terrinoni A, Ranalli M, Teofoli
P, Citro G, Scarpato S, Puddu P,Melino G (2002) Expression
of transglutaminase 5 in normal and pathologic human ep-
idermis. J Invest Dermatol 119:670–677
Candi E, Oddi S, Terrinoni A, Paradisi A, Ranalli M, Finazzi-
Agro A, Melino G (2001) Transglutaminase 5 cross-links
loricrin, involucrin, and small proline-rich proteins in vitro.
J Biol Chem 276:35014–35023
Candi E, Schmidt R, Melino G (2005) The corniﬁed envelope:
a model of cell death in the skin. Nat Rev Mol Cell Biol 6:
328–340
Eckert RL, Sturniolo MT, Broome AM, Ruse M, Rorke EA
(2005) Transglutaminase function in epidermis. J Invest Der-
matol 124:481–492
Grenard P, Bates MK, Aeschlimann D (2001) Evolution of
transglutaminase genes: identiﬁcation of a transglutaminase
gene cluster on human chromosome 15q15: structure of the
gene encoding transglutaminase X and a novel gene family
member, transglutaminase Z. J Biol Chem 276:33066–
33078
Hamada T, McLean WHI, Ramsay M, Ashton GH, Nanda A,
Jenkins T, Edelstein I, South AP, Bleck O, Wessagowit V,
Mallipeddi R, Orchard GE, Wan H, Dopping-Hepenstal PJ,
Mellerio JE, Whittock NV, Munro CS, van Steensel MA,
Steijlen PM, Ni J, Zhang L, Hashimoto T, Eady RAJ,
McGrath JA (2002) Lipoid proteinosis maps to 1q21 and
is caused by mutations in the extracellular matrix protein 1
gene (ECM1). Hum Mol Genet 11:833–840
Hashimoto K, Hamzavi I, Tanaka K, Shwayder T (2000) Acral
peeling skin syndrome. J Am Acad Dermatol 43:1112–1119
Horn HM, Priestly GC, Eady RAJ, Tidman MJ (1997) The
prevalence of epidermolysis bullosa in Scotland. Br J Der-
matol 136:560–564
Huber M, Rettler I, Bernasconi K, Frenk E, Lavrijsen SP, Ponec
M, Bon A, Lautenschlager S, Schorderet DF, Hohl D (1995)
Mutations of keratinocyte transglutaminase in lamellar ich-
thyosis. Science 267:525–528
Judge MR, McLean WHI, Munro CS (2004) Disorders of ker-
atinization. In: Burns T, Breathnach S, Cox C, Grifﬁths C
(eds) Rook’s textbook of dermatology. Vol 2. Blackwell Sci-
entiﬁc, Oxford, pp 34.54–34.56
Kalinin AE, Kajava AV, Steinert PM (2002) Epithelial barrier
function: assembly and structural features of the corniﬁed
cell envelope. Bioessays 24:789–800
Kurban AK, Azar HA (1969) Familial continual skin peeling.
Br J Dermatol 81:191–195
Laiho E, Ignatius J, Mikkola H, Yee VC, Teller DC, Niemi
KM, Saarialho-Kere U, Kere J, Palotie A (1997) Transglu-
taminase 1 mutations in autosomal recessive congenital ich-
thyosis: private and recurrent mutations in an isolated pop-
ulation. Am J Hum Genet 61:529–538
Lane EB, McLean WHI (2004) Keratins and skin disorders. J
Pathol 204:355–366
Levy SB, Goldsmith LA (1982) The peeling skin syndrome. J
Am Acad Dermatol 7:606–613
Madison KC (2003) Barrier function of the skin: “la raison
d’etre” of the epidermis. J Invest Dermatol 121:231–241
Mevorah B, Frenk E, Saurat JH, Siegenthaler G (1987) Peeling
skin syndrome: a clinical, ultrastructural and biochemical
study. Br J Dermatol 116:117–125
Parmentier L, Blanchet-Bardon C, Nguyen S, Prud’homme JF,
Dubertret L, Weissenbach J (1995) Autosomal recessive la-
mellar ichthyosis: identiﬁcation of a new mutation in trans-
glutaminase 1 and evidence for genetic heterogeneity. Hum
Mol Genet 4:1391–1395
Russell LJ, DiGiovanna JJ, Rogers GR, Steinert PM, Hashem
N, Compton JG, Bale SJ (1995) Mutations in the gene for
transglutaminase 1 in autosomal recessive lamellar ichthy-
osis. Nat Genet 9:279–283
Rybicki AC, Heath R, Wolf JL, Lubin B, Schwartz RS (1988)
Deﬁciency of protein 4.2 in erythrocytes from a patient with
a Coombs negative hemolytic anemia: evidence for a role of
protein 4.2 in stabilizing ankyrin on the membrane. J Clin
Invest 81:893–901
Sali A, Blundell TL (1993) Comparative protein modelling by
satisfaction of spatial restraints. J Mol Biol 234:779–815
Shwayder T, Conn S, Lowe L (1997) Acral peeling skin syn-
drome. Arch Dermatol 133:535–536
Silverman AK, Ellis CN, Beals TF, Woo TY (1986) Continual
skin peeling syndrome: an electron microscopic study. Arch
Dermatol 122:71–75
Traupe H (1989) The ichthyoses: a guide to clinical diagnosis,
genetic counselling, and therapy. Springer-Verlag, Berlin
Uitto J, Richard G (2004) Progress in epidermolysis bullosa:
genetic classiﬁcation and clinical implications. Am J Med
Genet C Semin Med Genet 131C:61–74
van Steensel MAM, Smith FJD, Steijlen PM, Kluijt I, Stevens
HP, Messenger A, Kremer H, Dunnill MG, Kennedy C,
Munro CS, Doherty VR, McGrath JA, Covello SP, Coleman
CM, Uitto J, McLean WHI (1999) The gene for hypotri-
chosis of Marie Unna maps between D8S258 and D8S298:
exclusion of the hr gene by cDNA and genomic sequencing.
Am J Hum Genet 65:413–419
